Evidence map›Paper›PMID 38558215›Full record

ArticleGeroScience2024

Neurobehavioral dysfunction in a mouse model of Down syndrome: upregulation of cystathionine β-synthase, H

Theodora Panagaki, Lucia Janickova, Dunja Petrovic, Karim Zuhra, Tamás Ditrói, Eszter P Jurányi, Olivier Bremer, Kelly Ascenção, Thilo M Philipp, Péter Nagy and 2 more

Open access · hybridAbstract read
In one paragraph

Article in GeroScience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
9.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Research square · 2026
    Article
  5. Hydrogen Sulfide Signaling in Neurodegenerative Movement Disorders.Handbook of experimental pharmacology · 2026
    Review
  6. Cystathionine γ-lyase is a major regulator of cognitive function through neurotrophin signaling and neurogenesis.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. The potential role of hydrogen sulfide-autophagy axis in diseases.Journal of physiology and biochemistry · 2025
    Review
  8. Black gas, bright future: HNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  9. Role of cystathionine-β-synthase and hydrogen sulfide in down syndrome.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  10. Hydrogen sulfide/polysulfides signaling and neuronal diseases.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  11. Cyanide overproduction impairs cellular bioenergetics in Down syndrome.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Article
  12. Article
  13. Article
  14. Emerging roles of hydrogen sulfide-metabolizing enzymes in cancer.Redox report : communications in free radical research · 2024
    Review
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Theodora Panagaki *Chair of Pharmacology, Section of Science and Medicine, University of Fribourg, Fribourg, Switzerland.
Lucia Janickova *Chair of Pharmacology, Section of Science and Medicine, University of Fribourg, Fribourg, Switzerland.
Dunja PetrovicLeibniz-Institut Für Analytische Wissenschaften-ISAS-E.V., Dortmund, Germany.
Karim ZuhraChair of Pharmacology, Section of Science and Medicine, University of Fribourg, Fribourg, Switzerland.
Tamás DitróiDepartment of Molecular Immunology and Toxicology and the National Tumor Biology Laboratory, National Institute of Oncology, Budapest, Hungary.
Eszter P JurányiDepartment of Molecular Immunology and Toxicology and the National Tumor Biology Laboratory, National Institute of Oncology, Budapest, Hungary.
Olivier BremerChair of Pharmacology, Section of Science and Medicine, University of Fribourg, Fribourg, Switzerland.
Kelly AscençãoChair of Pharmacology, Section of Science and Medicine, University of Fribourg, Fribourg, Switzerland.
Thilo M PhilippChair of Pharmacology, Section of Science and Medicine, University of Fribourg, Fribourg, Switzerland.
Péter NagyDepartment of Molecular Immunology and Toxicology and the National Tumor Biology Laboratory, National Institute of Oncology, Budapest, Hungary.
Milos R FilipovicLeibniz-Institut Für Analytische Wissenschaften-ISAS-E.V., Dortmund, Germany.
Csaba SzaboChair of Pharmacology, Section of Science and Medicine, University of Fribourg, Fribourg, Switzerland. csaba.szabo@unifr.ch.ORCID 0000-0003-3110-4235
University of Fribourg · CHLeibniz Institute for Analytical Sciences - ISAS · DENational Institute of Oncology · HUSemmelweis University · HUUniversity of Debrecen · HU

Funding

European Research Council 864921
6 · The paper itself

Abstract

Down syndrome (DS) is a genetic condition where the person is born with an extra chromosome 21. DS is associated with accelerated aging; people with DS are prone to age-related neurological conditions including an early-onset Alzheimer's disease. Using the Dp(17)3Yey/ + mice, which overexpresses a portion of mouse chromosome 17, which encodes for the transsulfuration enzyme cystathionine β-synthase (CBS), we investigated the functional role of the CBS/hydrogen sulfide (H

Indexed as

AutophagyCystathionine beta-SynthaseDisease Models, AnimalDown SyndromeEndoplasmic Reticulum StressHydrogen SulfideUp-RegulationAminooxyacetic AcidAnimalsBehavior, AnimalBrainFemaleMaleMiceSynapsesAminooxyacetic AcidCystathionine beta-SynthaseHydrogen SulfideAstrocytesBrainCognitionGasotransmittersGliosisMetabolismPersulfidation

Identifiers

PMID38558215
PMCPMC11336008
OpenAlexW4393380736

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.